Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 50891-50900 Newer>

The Motley Fool August 7, 2011 Morgan Housel	Credit Downgrade: What to Expect This Week Thoughts on the unknown. Now that America's credit rating has been downgraded, how is Mr. Market going to respond when the markets open tomorrow morning?
The Motley Fool August 7, 2011 Rex Moore	Procter & Gamble's Growth May Not Be What It Seems Because of its stellar history, I do give this company the benefit of the doubt.
The Motley Fool August 7, 2011 Rex Moore	Let's See If Caterpillar's Growth Is for Real Caterpillar appears to be in good shape in terms of the intangible assets ratio and tangible book value.
The Motley Fool August 6, 2011 Rex Moore	Let's See If Apple's Growth Is for Real Apple appears to be in good shape in terms of the intangible assets ratio and tangible book value. You can never base an entire investment thesis on one or two metrics, but there are no yellow flags here.
The Motley Fool August 6, 2011 Rex Moore	Let's See If AMD Is Hiding Weakness Advanced Micro Devices carries $342 million of goodwill and other intangibles on its balance sheet.
The Motley Fool August 6, 2011 Rex Moore	Let's See If Micron Technology's Growth Is for Real Micron Technology appears to be in good shape in terms of the intangible assets ratio and tangible book value.
The Motley Fool August 6, 2011 Rex Moore	Warning: Sprint Nextel May Be Hiding Weakness Here are Sprint Nextel's numbers, as well as a bonus look at a few other companies in its industry.
The Motley Fool August 6, 2011 Selwyn Parker	My Years With Rupert Murdoch A view of a media baron from the peanut stalls.
The Motley Fool August 6, 2011 Brad Loncar	An Open Letter to Dendreon's Chairman A plea to get the company back on track.
The Motley Fool August 6, 2011 Sean Williams	10 Large Caps to Rule Them All There's nothing generic about this company. For the inaugural large-cap pick, I think we should revisit pharma's most impervious pipeline, Teva Pharmaceuticals.
<Older 50891-50900 Newer> Return to current articles.